CFAP46: A Drug Target / Disease Biomarker (G54777)

Target Name: CFAP46

NCBI ID: G54777

CFAP46

CFAP46: A Drug Target / Disease Biomarker

CFAP46 is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nails. It is a member of the transforming growth factor family (TGF-β), which is a well-known signaling pathway that is involved in cell growth, differentiation, and repair.

CFAP46 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions has been explored in various studies, and its potential as a drug has been discussed in the scientific literature.

One of the key functions of CFAP46 is its role in cell signaling. It is a potent positive regulator of the TGF-β pathway, which is involved in the development and maintenance of tissues and organs. This pathway is a key factor in the development of cancer, as abnormal TGF-β signaling has been implicated in the development of many types of cancer.

In addition to its role in cell signaling, CFAP46 is also involved in several other cellular processes. For example, it has been shown to play a role in cell migration, and has been shown to be involved in the development and maintenance of the nervous system.

CFAP46 has also been shown to be involved in several diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that CFAP46 is often expressed in various types of cancer, and that it may be a useful biomarker for these conditions.

In addition to its potential as a drug target, CFAP46 is also of interest as a potential biomarker. Its expression has been shown to be altered in a variety of diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that it may be a useful tool for the diagnosis and treatment of these conditions.

CFAP46 is also of interest as a potential therapeutic target. Studies have shown that inhibiting CFAP46 can be effective in treating several types of cancer, including breast, lung, and ovarian cancer. In addition, studies have shown that inhibiting CFAP46 can be effective in treating neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

In conclusion, CFAP46 is a protein that is expressed in various tissues throughout the body that is involved in several cellular processes. Its role in cell signaling and its involvement in the development and maintenance of tissues and organs make it a potential drug target. Its potential as a biomarker and therapeutic target make it a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand its role and potential as a drug target.

Protein Name: Cilia And Flagella Associated Protein 46

Functions: As part of the central apparatus of the cilium axoneme plays a role in cilium movement

The "CFAP46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets